Nonprofit co-founded by Mayo Clinic announces plan to manufacture affordable insulin

Civica Rx, a nonprofit generic drug company, announced plans on Thursday, March 3, to manufacture and distribute affordable insulin. Mayo Clinic joined a coalition of seven hospitals to launch Civica Rx in 2018. The goal was to help patients by addressing supply shortages and high prices for medications. The availability of affordable insulin will benefit people with diabetes who have been forced to choose between life-sustaining medications and living expenses, particularly those uninsured and underinsured,…
Source: News from Mayo Clinic - Category: Databases & Libraries Source Type: news